CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
UNITY Vitreoretinal Cataract System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06165744
NCT06165744N/ACompleted

Next Generation Cataract and Vitreoretinal Surgery Study

Alcon Research·interventional·Posted Dec 11, 2023·Updated Jun 25, 2025

In Brief

A clinical study evaluating UNITY Vitreoretinal Cataract System and Posterior segment surgery in the operating room with or without simultaneous cataract surgery for Vitreoretinal Disease With or Without Cataracts. Completed, enrolled 120 participants across 5 sites.

Detailed Summary

The purpose of this study is to obtain device-specific safety and performance clinical data to support marketability in Europe and to collect formal user feedback.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedDec 11, 2023
Enrollment StartFeb 27, 2024
Primary CompletionMay 23, 2024
Study CompletionAug 19, 2024
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 2.6 years ago

Interventions

UNITY Vitreoretinal Cataract Systemdevice

UNITY Vitreoretinal Cataract System (VCS) with console, remote control, foot controller, UNITY TOTAL PLUS Combined Procedure Pak, and additional devices as needed to complete surgery

Posterior segment surgery in the operating room with or without simultaneous cataract surgeryprocedure

Posterior segment surgery involves removal of the vitreous (i.e., vitrectomy) followed by additional interventions as needed. Cataract surgery involves removal of the crystalline lens (which is often cloudy).